Japan Pharma Climbing Aboard Digital Health Train, But Not Up To Speed?
The still somewhat loosely defined concept of 'digital health' continues to take concrete forms through recent deals in Japan, where major pharma firms are building initiatives related mainly to patient well-being.
You may also be interested in...
Pharma is leveraging new commercial models in China as part of strategies to offset centralized procurements-induced market share losses and also for new launches, the co- founder of Indegene, a healthtech solutions provider, tells Scrip. He also shares insights on how companies in Japan are shifting digital gears amid COVID-19.
Digital health initiatives are rapidly emerging in Asia amid robust innovation and rising R&D activities in the region, but there are still some hurdles to overcome. An executive from Pfizer talks to Scrip about some of the major trends, opportunities and challenges.
Japan's complex reimbursement pricing system was further tweaked in April in a bid to raise the bar for innovation while controlling costs. What are the main changes and is industry happy?